Abstract
Two independent equations were recently proposed for estimating 177Lu-cetuximab cumulative activity, in a preclinical situation, from an initial 64Cu-cetuximab diagnostic scan acquired at peak time of decay-uncorrected (t peak-uncorr) or decay-corrected (t peak-corr) time–activity curve of trapped 64Cu-cetuximab, respectively. The standard uptake ratio (SUR) measured at t peak-uncorr or t peak-corr turned out to be a key metric in each equation, respectively. However, acquiring the diagnostic scan at t peak-uncorr or t peak-corr might be a limitation of the proposed method. Therefore, in an attempt to overcome this limitation, this note aims at theoretically investigating whether SUR(t peak-uncorr) and/or SUR(t peak-corr) could be derived from a diagnostic scan acquired at any time postinjection.
Get full access to this article
View all access options for this article.